Standout Papers
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease (2008)
- Genetics and epigenetics of NAFLD and NASH: Clinical impact (2017)
- Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects (2012)
- Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance (2023)
- The first
MASH drug therapy on the horizon: Current perspectives of resmetirom (2024)
Immediate Impact
1 by Nobel laureates 7 from Science/Nature 136 standout
Citing Papers
Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution
2025 Standout
Tirzepatide for Obesity Treatment and Diabetes Prevention
2024 Standout
Works of Stefano Romeo being referenced
Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects
2012 Standout
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Stefano Romeo | 7121 | 4358 | 1835 | 2019 | 198 | 11.5k | |
| Carlos J. Pirola | 4951 | 2991 | 2414 | 1198 | 182 | 9.1k | |
| Christopher Liddle | 4406 | 2538 | 4377 | 1835 | 155 | 14.1k | |
| Jürgen Machann | 4499 | 2626 | 2463 | 644 | 232 | 11.4k | |
| Yasuo Terauchi | 4215 | 5280 | 7719 | 373 | 375 | 16.9k | |
| Andreas L. Birkenfeld | 2467 | 4282 | 3104 | 247 | 268 | 10.2k | |
| Franco Folli | 1696 | 3479 | 3878 | 401 | 193 | 12.6k | |
| Takenobu Kamada | 2999 | 538 | 2391 | 2848 | 307 | 11.4k | |
| Masato Furuhashi | 3286 | 1283 | 4515 | 267 | 203 | 9.9k | |
| Antti Hakkarainen | 2782 | 2023 | 1163 | 543 | 110 | 5.1k | |
| Nicolas Musi | 3209 | 3915 | 8559 | 287 | 142 | 15.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...